An international, multi-centered clinical trial of AVA-202
Latest Information Update: 18 Jul 2019
At a glance
- Drugs AVA 202 (Primary)
- Indications Diabetic foot ulcer; Vascular disorders
- Focus Adverse reactions
Most Recent Events
- 18 Jul 2019 New trial record
- 15 Jul 2019 According to an Avalon GloboCare media release, the company plans to initiate this study during Q4 of 2019.